Palvella Therapeutics (PVLA) Return on Sales (2016 - 2024)
Historic Return on Sales for Palvella Therapeutics (PVLA) over the last 11 years, with Q4 2024 value amounting to 21.83%.
- Palvella Therapeutics' Return on Sales rose 111700.0% to 21.83% in Q4 2024 from the same period last year, while for Dec 2024 it was 136.2%, marking a year-over-year increase of 1364400.0%. This contributed to the annual value of 40.54% for FY2024, which is 401100.0% up from last year.
- As of Q4 2024, Palvella Therapeutics' Return on Sales stood at 21.83%, which was up 111700.0% from 0.26% recorded in Q3 2024.
- In the past 5 years, Palvella Therapeutics' Return on Sales registered a high of 21.83% during Q4 2024, and its lowest value of 47.85% during Q1 2024.
- For the 5-year period, Palvella Therapeutics' Return on Sales averaged around 2.73%, with its median value being 0.99% (2021).
- Per our database at Business Quant, Palvella Therapeutics' Return on Sales skyrocketed by 125700bps in 2023 and then crashed by -403100bps in 2024.
- Over the past 5 years, Palvella Therapeutics' Return on Sales (Quarter) stood at 6.61% in 2020, then soared by 80bps to 1.3% in 2021, then plummeted by -47bps to 1.91% in 2022, then skyrocketed by 658bps to 10.66% in 2023, then skyrocketed by 105bps to 21.83% in 2024.
- Its Return on Sales was 21.83% in Q4 2024, compared to 0.26% in Q3 2024 and 0.2% in Q2 2024.